Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation

Cited by (1,005)

Items 101–200 of 1,005

1. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation
   Craig T. January, L. Samüel Wann, Hugh G Calkins, Lin Y. Chen, Joaquin E. Cigarroa, Joseph C. Cleveland, Patrick T. Ellinor, Michael D. Ezekowitz, Michael E. Field, Karen L. Furie et al. · 2019 · Heart Rhythm
2. Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated
   David J. Gladstone, Esther Bui, Jiming Fang, Andreas Laupacis, M. Patrice Lindsay, Jack V. Tu, Frank L. Silver, Moira K. Kapral · 2008 · Stroke
3. Stroke prevention in atrial fibrillation: Past, present and future
   Gregory Y.H. Lip, Ben Freedman, Raffaele De Caterina, Tatjana Potpara · 2017 · Thrombosis and Haemostasis
4. 2020 Clinical practice guidelines for Chronic heart failure
   Russian Society of Cardiology · 2020 · Russian Journal of Cardiology
5. Challenges in the design and interpretation of Noninferiority trials
   Mauri, Laura, D’Agostino, Ralph B. · 2017 · New England Journal of Medicine
6. Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation
   Francesco Dentali, Nicoletta Riva, Mark Andrew Crowther, Alexander G.G. Turpie, Gregory Y.H. Lip, Walter Ageno · 2012 · Circulation
7. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods
   Hooman Kamel, W. T. Longstreth, David Tirschwell, Richard A. Kronmal, Joseph P. Broderick, Yuko Y. Palesch, Caitlyn Meinzer, Catherine Dillon, Irene Ewing, Judith A. Spilker et al. · 2018 · International Journal of Stroke
8. Antiplatelet Drugs
   John W. Eikelboom, Jack Hirsh, Frederick Alan Spencer, Trevor P Baglin, Jeffrey Ian Weitz · 2012 · CHEST Journal
9. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data
   Hughes, Michael, Lip, Gregory Y. H., on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care · 2008 · Thrombosis and Haemostasis
10. Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
    Sigrun Halvorsen, Dan Atar, H. Yang, Raffaele De Caterina, Çetin Erol, D. Garcia, Christopher Bull Granger, M. Hanna, Claes Held, Steen Husted et al. · 2014 · European Heart Journal
11. Parenteral anticoagulants in heart disease: Current status and perspectives (Section II)
    Steen Husted, Lars C. Wallentin, Felicita Andreotti, Harald Arnesen, F Bachmann, Colin Baigent, Kurt Huber, Jørgen Jespersen, Steen Dalby Kristensen, Gregory Y.H. Lip et al. · 2013 · Thrombosis and Haemostasis
12. Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries
    Jonas Oldgren, Jeff S. Healey, Michael D. Ezekowitz, Patrick Commerford, Álvaro Avezum, Prem S Pais, Jun Zhu, Petr Janský, Alben Sigamani, Carlos Arturo Morillo et al. · 2014 · Circulation
13. Atrial fibrillation in heart failure: what should we do?
    Dipak Kotecha, Jonathan Paul Piccini · 2015 · European Heart Journal
14. Vitamin K antagonists in heart disease: Current status and perspectives (Section III)
    Steen Husted, Lars C. Wallentin, Felicita Andreotti, Harald Arnesen, Fedor Bachmann, Colin Baigent, Kurt Huber, Jørgen Jespersen, Steen Dalby Kristensen, Gregory Y.H. Lip et al. · 2013 · Thrombosis and Haemostasis
15. Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study
    Steven A. Lubitz, Anthony Z. Faranesh, Caitlin Ann Selvaggi, Steven J. Atlas, David D. McManus, Daniel E. Singer, Sherry Pagoto, Michael V. McConnell, Alexandros Pantelopoulos, Andrea S. Foulkes · 2022 · Circulation
16. Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
    Arlene M. Gallagher, Efrosini Setakis, Jonathan Plumb, Andreas Clemens, Tjeerd Pieter van Staa · 2011 · Thrombosis and Haemostasis
17. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
    Hankey, Graeme J, Patel, Manesh R, Stevens, Susanna R, Becker, Richard C, Breithardt, Günter, Carolei, Antonio, Diener, Hans-Christoph, Donnan, Geoffrey A, Halperin, Jonathan L, Mahaffey, Kenneth W et al. · 2012 · The Lancet Neurology
18. Dabigatran Etexilate
    Graeme J. Hankey, John W. Eikelboom · 2011 · Circulation
19. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
    Neena S. Abraham, Sonal Singh, G. Caleb Alexander, Herbert C. Heien, Lindsey R. Haas, William H. Crown, Nilay D. Shah · 2015 · BMJ
20. Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation
    David Conen · 2011 · JAMA
21. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
    Peter Brønnum Nielsen, Flemming Skjøth, Mette Søgaard, Jette Nordstrøm Kjældgaard, Gregory Y.H. Lip, Torben Bjerregaard Larsen · 2017 · BMJ
22. Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation
    Stuart J. Connolly, Indravadan J. Patel, Daniel E. Salazar, Shashank Rohatagi, Jeanne Mendell, Helen Kastrissios, Jianqing Jin, Satoshi Kunitada, Jeffrey Ian Weitz · 2010 · Thrombosis and Haemostasis
23. Atrial fibrillation
    Gregory Y.H. Lip, Hung‐Fat Tse, Deirdre A. Lane · 2011 · The Lancet
24. Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
    Shimoli V. Shah, Brian F. Gage · 2011 · Circulation
25. Screening to identify unknown atrial fibrillation: A systematic review
    Lowres, Nicole, Neubeck, Lis, Redfern, Julie, Freedman, S. Ben · 2013 · Thrombosis and Haemostasis
26. The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis
    Chatree Chai‐Adisaksopha, Mark Andrew Crowther, Tetsuya Isayama, Wendy Lim · 2014 · Blood
27. Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients
    Gregory Y.H. Lip, Allison V. Keshishian, Xiaoyan Li, Melissa Hamilton, Cristina Masseria, Kiran B. Gupta, Xuemei Luo, Jack Mardekian, Keith E. Friend, Anagha Nadkarni et al. · 2018 · Stroke
28. Stroke Prevention in Atrial Fibrillation
    Gregory Y.H. Lip, Deirdre A. Lane · 2015 · JAMA
29. Atrial fibrillation after isolated coronary surgery affects late survival
    Mariscalco, Giovanni, Klersy, Catherine, Zanobini, Marco, Banach, Maciej, Ferrarese, Sandro, Borsani, Paolo, Cantore, Cristiano, Biglioli, Paolo, Sala, Andrea · 2008 · Circulation
30. CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant
    Matthew G. McDonald, Mark J. Rieder, Mariko Nakano, Clara K. Hsia, Allan E. Rettie · 2009 · Molecular Pharmacology
31. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES
    Vanassche, T., Lauw, M. N., Eikelboom, J. W., Healey, J. S., Hart, R. G., Alings, M., Avezum, A., Diaz, R., Hohnloser, S. H., Lewis, B. S. et al. · 2015 · European Heart Journal
32. Causes of Death and Influencing Factors in Patients With Atrial Fibrillation: A Competing-Risk Analysis From the Randomized Evaluation of Long-Term Anticoagulant Therapy Study
    Marijon, Eloi, Le Heuzey, Jean-Yves, Connolly, Stuart, Yang, Sean, Pogue, Janice, Brueckmann, Martina, Eikelboom, John, Themeles, Ellison, Ezekowitz, Michael, Wallentin, Lars et al. · 2013 · Circulation
33. Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation
    David J. Graham, Marsha E. Reichman, Michael Wernecke, Ya-Hui Hsueh, Rima Izem, Mary Ross Southworth, Yuqin Wei, Jiemin Liao, Margie R. Goulding, Katrina Mott et al. · 2016 · JAMA Internal Medicine
34. Deep neural networks can predict new-onset atrial fibrillation from the 12-lead ECG and help identify those at risk of atrial fibrillation-related stroke
    Raghunath, Sushravya, Pfeifer, John M., Ulloa-Cerna, Alvaro E., Nemani, Arun, Carbonati, Tanner, Jing, Linyuan, vanMaanen, David P., Hartzel, Dustin N., Ruhl, Jeffery A., Lagerman, Braxton F. et al. · 2021 · Circulation
35. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial
    Ordi-Ros, Josep, Sáez-Comet, Luis, Pérez-Conesa, Mercedes, Vidal, Xavier, Riera-Mestre, Antoni, Castro-Salomó, Antoni, Cuquet-Pedragosa, Jordi, Ortiz-Santamaria, Vera, Mauri-Plana, Montserrat, Solé, Cristina et al. · 2019 · Annals of Internal Medicine
36. National Trends in Oral Anticoagulant Use in the United States, 2007 to 2011
    Kate Kirley, Dima Mazen Qato, Rachel Kornfield, Randall Scott Stafford, G. Caleb Alexander · 2012 · Circulation Cardiovascular Quality and Outcomes
37. Automated detection of atrial fibrillation using long short-term memory network with RR interval signals
    Oliver Faust, Alex Shenfield, Murtadha Kareem, Tan Ru San, Hamido Fujita, U. Rajendra Acharya · 2018 · Computers in Biology and Medicine
38. Sex differences in stroke: Challenges and opportunities
    Cheryl Bushnell, Seemant Chaturvedi, Kathy R Gage, Paco S. Herson, Patricia D. Hurn, Monik C. Jiménez, Steven J. Kittner, Tracy E. Madsen, Louise D. McCullough, Mollie McDermott et al. · 2018 · Journal of Cerebral Blood Flow & Metabolism
39. Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
    Kurt Huber, Felicita Andreotti, Harald Arnesen, Juhani K.E. Airaksinen, Thomas Cuisset, Paulus F. Kirchhof, Francisco R. Marín, Gregory Y.H. Lip · 2009 · Thrombosis and Haemostasis
40. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines
    Andrew Veitch, Geoffroy Vanbiervliet, Anthony Gershlick, Christian Boustière, Trevor P Baglin, Lesley‐Ann Smith, Franco Radaelli, Evelyn Knight, Ian Mark Gralnek, Cesare Hassan et al. · 2016 · Gut
41. Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms
    Javad Sharifi‐Rad, Natália Alves Martins, Pía López‐Jornet, Eduardo Pons-Fuster, Nidaa Harun, Balakyz Kymyzgalievna Yeskaliyeva, Ahmet Beyatlı, Oksana Sytar, Shabnum Shaheen, Farukh S. Sharopov et al. · 2021 · Oxidative Medicine and Cellular Longevity
42. Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society
    Cecilia Marianne Linde, Maria Grazia Bongiorni, Ulrika Maria Birgersdotter-Green, Anne B. Curtis, Isabel Deisenhofer, Tetsushi Furokawa, Anne M. Gillis, Kristina Hermann Haugaa, Gregory Y.H. Lip, Isabelle C. Van Gelder et al. · 2018 · EP Europace
43. Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control
    Christopher Ll. Morgan, Phil C. McEwan, Andrzej Tukiendorf, Paul A. Robinson, Andreas Clemens, Jonathan M. Plumb · 2008 · Thrombosis Research
44. Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk
    Jonathan Chong Hsu, Thomas M. Maddox, Kevin F. Kennedy, David F. Katz, Lucas Marzec, Steven A. Lubitz, Anil K. Gehi, Mintu P. Turakhia, Gregory M. Marcus · 2016 · JAMA Cardiology
45. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter
    John A. Cairns, Stuart J. Connolly, Sean McMurtry, Michael Stephenson, Mario R. Talajic · 2011 · Canadian Journal of Cardiology
46. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke
    Sólveig Grétarsdóttir, Guðmar Þorleifsson, Andrei R. Manolescu, Unnur Styrkársdóttir, Anna Helgadóttir, Andreas Gschwendtner, Konstantinos Kostulas, Gregor Kuhlenbäumer, Steve Bevan, Þorbjörg Jónsdóttir et al. · 2008 · Annals of Neurology
47. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study
    Jeff S. Healey, Jonas Oldgren, Michael D. Ezekowitz, Jun Zhu, Prem Pais, Jia Wang, Patrick Commerford, Petr Janský, Álvaro Avezum, Alben Sigamani et al. · 2016 · The Lancet
48. Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
    Y. Vinogradova, C. Coupland, T. Hill, J. Hippisley-Cox · 2018 · British medical journal
49. Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease
    Anders Nissen Bonde, Gregory Y.H. Lip, Anne‐Lise Kamper, Peter Riis Hansen, Morten Lamberts, Kristine Hommel, Morten Lock Hansen, Gunnar Gislason, Christian Tobias Torp-Pedersen, Jonas Bjerring Olesen · 2014 · Journal of the American College of Cardiology
50. Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AF RANDOMISED ): an open-label randomised controlled trial
    Rolf Wachter, Klaus Gröschel, Götz Gelbrich, Gerhard F. Hamann, Pawel Kermer, Jan Liman, Joachim Seegers, Katrin Wasser, Anna Schulte, Falko Jürries et al. · 2017 · The Lancet Neurology
51. Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
    Mark H. Eckman, Jonathan M. Rosand, Steven Mark Greenberg, Brian F. Gage · 2009 · Annals of Internal Medicine
52. The Changing Landscape for Stroke Prevention in AF
    Menno Volkert Huisman, Kenneth Jay Rothman, Miney Paquette, Christine Teutsch, Hans‐Christoph Diener, Sérgio Dubner, Jonathan L. Halperin, Chang Sheng, Kristina Zint, Amelie Elsaesser et al. · 2017 · Journal of the American College of Cardiology
53. Moving the Tipping Point
    Mark H. Eckman, Daniel E. Singer, Jonathan M. Rosand, Steven Mark Greenberg · 2010 · Circulation Cardiovascular Quality and Outcomes
54. Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation
    Stuart J. Connolly, Ganesan Karthikeyan, Mpiko Ntsekhe, Abraham Haileamlak, Ahmed El Sayed, Alaa Elghamrawy, Albertino Antonio Moura Damasceno, Álvaro Avezum, Antonio L. Dans, Bernard Gitura et al. · 2022 · New England Journal of Medicine
55. Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
    Matthew William Sherwood, James Demetrios Douketis, Manesh R. Patel, Jonathan Paul Piccini, Anne S. Hellkamp, Yuliya V. Lokhnygina, Alex C. Spyropoulos, Graeme J. Hankey, Daniel E. Singer, Christopher C. Nessel et al. · 2014 · Circulation
56. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study
    Nielsen, Peter Brønnum, Larsen, Torben Bjerregaard, Skjøth, Flemming, Gorst-Rasmussen, Anders, Rasmussen, Lars Hvilsted, Lip, Gregory Y.H. · 2015 · Circulation
57. Causes of Death in Anticoagulated Patients With Atrial Fibrillation
    Antonio Gómez‐Outes, Julián Lagunar-Ruíz, Ana‐Isabel Terleira‐Fernández, Gonzalo Calvo, Maria Luisa Suárez-Gea, Emilio Vargas · 2016 · Journal of the American College of Cardiology
58. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA
    Mattias Wieloch, Anders Själander, Viveka Frykman, Mårten Rosenqvist, Niclas Eriksson, Peter J. Svensson · 2011 · European Heart Journal
59. Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter
    Stuart J. Connolly, Harry J.G.M. Crijns, Christian Tobias Torp-Pedersen, Martin van Eickels, Christophe Gaudin, Richard L. Page, Stefan Hans Hohnloser · 2009 · Circulation
60. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation
    Lucas Marzec, Jingyan Wang, Nilay D. Shah, Paul S. Chan, Henry H. Ting, KENSEY L. GOSCH, Jonathan Chong Hsu, Thomas M. Maddox · 2017 · Journal of the American College of Cardiology
61. Self-monitoring and self-management of oral anticoagulation
    Carl J. Heneghan, Josep Maria Garcia-Alamino, Elizabeth A. Spencer, Alison M. Ward, Rafael Perera, Clare R Bankhead, Pablo Alonso‐Coello, David Andrew Fitzmaurice, Kamal Ram Mahtani, Igho Onakpoya · 2016 · Cochrane Database of Systematic Reviews
62. Atrial Fibrillation
    Mina K. Chung, Marwan M. Refaat, Win-Kuang Shen, Valentina Kutyifa, Yong‐Mei Cha, Luigi Di Biase, Adrian M Baranchuk, Rachel Lampert, Andrea Natale, John D. Fisher et al. · 2020 · Journal of the American College of Cardiology
63. Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial
    Noseworthy, Peter A, Attia, Zachi I, Behnken, Emma M, Giblon, Rachel E, Bews, Katherine A, Liu, Sijia, Gosse, Tara A, Linn, Zachery D, Deng, Yihong, Yin, Jun et al. · 2022 · The Lancet
64. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study
    Duncan Wilson, Gareth Ambler, Clare Shakeshaft, Martin M. Brown, Andreas Charidimou, Rustam Al‐Shahi Salman, Gregory Y.H. Lip, Hannah Cohen, Gargi Banerjee, Henry Houlden et al. · 2018 · The Lancet Neurology
65. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE).
    G. Mairesse, P. Moran, I. V. van Gelder, C. Elsner, M. Rosenqvist, J. Mant, A. Banerjee, B. Gorenek, J. Brachmann, N. Varma et al. · 2018 · Europace
66. Diagnostic Performance of a Smartphone‐Based Photoplethysmographic Application for Atrial Fibrillation Screening in a Primary Care Setting
    Chan, Pak‐Hei, Wong, Chun‐Ka, Poh, Yukkee C., Pun, Louise, Leung, Wangie Wan‐Chiu, Wong, Yu‐Fai, Wong, Michelle Man‐Ying, Poh, Ming‐Zher, Chu, Daniel Wai‐Sing, Siu, Chung‐Wah · 2016 · Journal of the American Heart Association
67. Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials
    William F. McIntyre, Alexander Philipp Benz, Nina Becher, Jeff S. Healey, Christopher Bull Granger, Léna Rivard, A. John Camm, Andreas Goette, Antonia Zapf, Marco Alings et al. · 2023 · Circulation
68. Atrial fibrillation and stroke prevention
    Gregory Y.H. Lip, Hoong Sern Lim · 2007 · The Lancet Neurology
69. Atrial Fibrillation
    PETER J. ZIMETBAUM · 2017 · Annals of Internal Medicine
70. Trends in the prescription of novel oral anticoagulants in UK primary care
    Simone Y. Loo, Sophie Dell’Aniello, Laëtitia Huiart, Christel Renoux · 2017 · British Journal of Clinical Pharmacology
71. Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
    Felicita Andreotti, Bianca Rocca, Steen Husted, Ramzi Ajjan, Jurriën M. ten Berg, Marco Cattaneo, Jean‐Philippe Collet, Raffaele De Caterina, Keith A.A. Fox, Sigrun Halvorsen et al. · 2015 · European Heart Journal
72. Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial
    Sean D. Pokorney, Glenn Matthew Chertow, Hussein R. Al‐Khalidi, Dianne S. Gallup, Patricia Dignacco, Kurt Mussina, Nisha Bansal, Crystal Ann Gadegbeku, David A. Garcia, Samira J. Merali et al. · 2022 · Circulation
73. Atrial fibrillation
    Gregory Y.H. Lip, Laurent Fauchier, Saul B. Freedman, Isabelle C. Van Gelder, Andrea Natale, Carola Gianni, Stanley Nattel, Tatjana Potpara, Michiel Rienstra, Hung‐Fat Tse et al. · 2016 · Nature Reviews Disease Primers
74. Addressing between‐study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non‐rheumatic atrial fibrillation
    Nicola J. Cooper, Alex J. Sutton, Danielle H. Morris, Anthony E. Ades, Nicky J. Welton · 2009 · Statistics in Medicine
75. Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation
    Kang-Ling Wang, Gregory Y.H. Lip, Shing‐Jong Lin, Chern‐En Chiang · 2015 · Stroke
76. Heart failure with reduced ejection fraction
    Michelle Weisfelner Bloom, Barry Greenberg, Tiny Jaarsma, James L. Januzzi, Carolyn S.P. Lam, Aldo Pietro Maggioni, Jean‐Noël Trochu, Javed Butler · 2017 · Nature Reviews Disease Primers
77. 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
    Jason G. Andrade, Atul Verma, L. Brent Mitchell, Ratika Parkash, Kori Leblanc, Clare L. Atzema, Jeff S. Healey, Alan Bell, John A. Cairns, Stuart J. Connolly et al. · 2018 · Canadian Journal of Cardiology
78. Age as a Risk Factor for Stroke in Atrial Fibrillation Patients
    Marinigh, Ricarda, Lip, Gregory Y.H., Fiotti, Nicola, Giansante, Carlo, Lane, Deirdre A. · 2010 · Journal of the American College of Cardiology
79. Stroke Associated with Atrial Fibrillation – Incidence and Early Outcomes in the North Dublin Population Stroke Study
    Niamh Hannon, Orla C. Sheehan, Lisa Kelly, Michael Marnane, Áine Merwick, Alan R. Moore, Lorraine Kyne, Joseph Duggan, Joan T. Moroney, Patricia M. E. McCormack et al. · 2009 · Cerebrovascular Diseases
80. Management of atrial fibrillation
    Lip, Gregory YH, Tse, Hung-Fat · 2007 · The Lancet
81. Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)
    Adam J. Rose, Elaine M. Hylek, Al Ozonoff, Arlene S. Ash, Joel I. Reisman, Dan R. Berlowitz · 2010 · Journal of Thrombosis and Haemostasis
82. Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation
    David Conen, Nicolas Rodondi, Andreas S. Müller, Jürg Hans Beer, Peter Ammann, Giorgio Moschovitis, Angelo Auricchio, Daniel Hayoz, Richard Kobza, Dipen C. Shah et al. · 2019 · Journal of the American College of Cardiology
83. Pros and cons of new oral anticoagulants
    Kenneth Alan Bauer · 2013 · Hematology
84. 2020 Clinical guidelines for Atrial fibrillation and atrial flutter
    M. S. Arakelyan, Leo A. Bockeria, Elena Vasilieva, Golitsyn Sp, Elena Zelikovna Golukhova, M. V. Gorev, Karapet V. Davtyan, Oksana M. Drapkina, Кропачева Екатерина Станиславовна, Е. А. Kuchinskaya et al. · 2021 · Russian Journal of Cardiology
85. Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF
    Kevin E. Chan, Robert Patrick Giugliano, Manesh R. Patel, Stuart Abramson, Meg Jardine, Sophia J. Zhao, Vlado Perkovic, Franklin W. Maddux, Jonathan Paul Piccini · 2016 · Journal of the American College of Cardiology
86. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation
    Tze‐Fan Chao, Chia‐Jen Liu, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Jo‐Nan Liao, Fa‐Po Chung, Tzeng‐Ji Chen et al. · 2018 · Circulation
87. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines
    Andrew Veitch, Geoffroy Vanbiervliet, Anthony Gershlick, Christian Boustière, Trevor P Baglin, Lesley‐Ann Smith, Franco Radaelli, Evelyn Knight, Ian Mark Gralnek, Cesare Hassan et al. · 2016 · Endoscopy
88. Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
    Gregory Y.H. Lip, António Coca, Thomas Kahan, Giuseppe Boriani, Antonis S. Manolis, Michael Hecht Olsen, Ali̇ Oto, Tatjana Potpara, Jan Steffel, Francisco R. Marín et al. · 2017 · EP Europace
89. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke
    Rizos, Timolaos, Güntner, Janina, Jenetzky, Ekkehart, Marquardt, Lars, Reichardt, Christine, Becker, Rüdiger, Reinhardt, Roland, Hepp, Thomas, Kirchhof, Paulus, Aleynichenko, Elena et al. · 2012 · Stroke
90. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks
    Maria I. Aguilar, Robert G. Hart, Lesly A. Pearce · 2007 · Cochrane Database of Systematic Reviews
91. Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice
    Gregory Y.H. Lip, Hans‐Christoph Diener, Martina Brueckmann, Joanne van Ryn, Andreas Clemens, Menno Volkert Huisman · 2012 · Thrombosis and Haemostasis
92. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study
    Stuart J. Connolly, Lars C. Wallentin, Michael D. Ezekowitz, John W. Eikelboom, Jonas Oldgren, Paul A. Reilly, Martina Brueckmann, Janice M. Pogue, Marco Alings, John V. Amerena et al. · 2013 · Circulation
93. Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation
    Lars C. Wallentin, Renato D. Lópes, Michael Hanna, Laine Elliott Thomas, Anne S. Hellkamp, Sunil Nepal, Elaine M. Hylek, Sana M. Al‐Khatib, John Hunter Alexander, Marco Alings et al. · 2013 · Circulation
94. Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies
    Apostolos Tzikas, David R. Holmes, Sameer A. Gafoor, Carlos Eduardo Ruiz, Carina Blomström‐Lundqvist, Hans‐Christoph Diener, Riccardo Cappato, Saibal Kar, Randal J. Lee, Robert A. Byrne et al. · 2016 · EP Europace
95. Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
    Davide Capodanno, Roxana Mehran, Marco Valgimigli, Usman Baber, Stephan Windecker, Pascal Vranckx, George Dangas, Fabiana Rollini, Takeshi Kimura, Jean‐Philippe Collet et al. · 2018 · Nature Reviews Cardiology
96. Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease
    Marcello A. Tonelli, S. Ananth Karumanchi, Ravi Thadhani · 2016 · Circulation
97. Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses
    Joshua Pink, S. Lane, Munir Pirmohamed, Dyfrig Arwyn Hughes · 2011 · BMJ
98. 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy
    Shamir R. Mehta, Kevin R. Bainey, Warren J. Cantor, Marie Lordkipanidzé, Guillaume Marquis‐Gravel, Simon D. Robinson, Matthew Sibbald, Derek Y F So, Graham Christopher Wong, Joseph G. Abunassar et al. · 2017 · Canadian Journal of Cardiology
99. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial
    Dragoş Vinereanu, Renato D. Lópes, Maria Cecilia Bahit, Denis Xavier, Jie Jiang, Hussein R. Al‐Khalidi, Wensheng He, Ying Xian, Andrea Olivia Ciobanu, Deepak Y. Kamath et al. · 2017 · The Lancet
100. Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial
     Clarkesmith, Danielle E., Pattison, Helen M., Lip, Gregory Y. H., Lane, Deirdre A. · 2013 · PLoS ONE